These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 2435632
1. Greater decrease of fibrinogen as compared to antithrombin III in L-asparaginase treated leukemia patients. Vicarioto M, Rosolen A, Cappellato MG, Zanesco L, Girolami A. Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):663-9. PubMed ID: 2435632 [Abstract] [Full Text] [Related]
2. Hemostatic changes in children with acute lymphoblastic leukemia treated according to two different L-asparaginase schedules. Miniero R, Pastore G, Saracco P, Messina M, Lange MM, Fiandino G, Iannacci L, Madon E. Am J Pediatr Hematol Oncol; 1986; 8(2):116-20. PubMed ID: 3461716 [Abstract] [Full Text] [Related]
3. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study. Hunault-Berger M, Chevallier P, Delain M, Bulabois CE, Bologna S, Bernard M, Lafon I, Cornillon J, Maakaroun A, Tizon A, Padrazzi B, Ifrah N, Gruel Y, GOELAMS (Groupe Ouest-Est des Leucémies Aiguës et Maladies du Sang). Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028 [Abstract] [Full Text] [Related]
4. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia. Mall V, Thomas KB, Sauter S, Niemeyer CM, Sutor AH. Klin Padiatr; 1999 Oct; 211(4):205-10. PubMed ID: 10472551 [Abstract] [Full Text] [Related]
5. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia. Ortega JA, Nesbit ME, Donaldson MH, Hittle RE, Weiner J, Karon M, Hammond D. Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412 [Abstract] [Full Text] [Related]
6. [Acquired deficiencies in antithrombin III and C protein during treatment with L-asparaginase]. Mielot F, Danel P, Boyer C, Coulombel L, Dommergues JP, Tchernia G, Larrieu MJ. Arch Fr Pediatr; 1987 Mar; 44(3):161-5. PubMed ID: 2883953 [Abstract] [Full Text] [Related]
7. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000. Attarbaschi A, Mann G, Kronberger M, Witt V, Gadner H, Dworzak M. Klin Padiatr; 2003 Mar; 215(6):321-6. PubMed ID: 14677096 [Abstract] [Full Text] [Related]
12. L-asparaginase-induced hypocomplementemia in acute lymphocytic leukemia (ALL) of childhood. Shapiro R, Kim Y, Michael AF, Gerrard JM, Nesbit M, Coccia P, Ramsay NK, Krivit W. Am J Pediatr Hematol Oncol; 1979 Mar; 1(1):5-7. PubMed ID: 295575 [Abstract] [Full Text] [Related]
16. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG). van der Does-van den Berg A, van Wering ER, Suciu S, Solbu G, van 't Veer MB, Rammeloo JA, de Koning J, van Zanen GE. Am J Pediatr Hematol Oncol; 1989 Dec; 11(2):125-33. PubMed ID: 2665546 [Abstract] [Full Text] [Related]
17. Abnormal glucose tolerance in children with acute leukemia. Effect of induction chemotherapy including L-asparaginase. Dacou-Voutetakis C, Palis J, Haidas S, Zannos-Mariolea L, Georgiopoulou P, Matsaniotis N. Am J Pediatr Hematol Oncol; 1983 Dec; 5(2):139-46. PubMed ID: 6351658 [Abstract] [Full Text] [Related]